1-(4-Methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid

CAS : 503614-92-4

Ref. 3D-FM155764

Informations sur le produit

• Nom: 1-(4-Methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid

Description

Apixaban is a novel, orally active, and selective factor Xa inhibitor. It is the first oral anticoagulant that has been developed to inhibit both free and clot-bound thrombin. Apixaban binds reversibly to the active site of factor Xa and inhibits factor Xa-mediated conversion of prothrombin to thrombin, resulting in an increased concentration of prothrombin in blood. Apixaban also inhibits the activity of thrombin-activated protein C (APC) that degrades fibrin clots by proteolytic cleavage of fibrinogen. This drug has a crystalline form with a particle size between 10 and 100 μm.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 460.48 g/mol
• Formule: C₂₅H₂₄N₄O₅
• Degré de pureté: Min. 95%